Latest news and press releases about Definitive Healthcare Corp. (DH): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution.
Price
| Price | $0.96 |
| Market Cap | $102M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.70 |
| EV / EBITDA | -0.55 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -78.52% |
| Return on Invested Capital | 40.78% |
| Return on Assets | -33.85% |
| Gross Margin | 71.67% |
| Operating Margin | 67.38% |
| Net Margin | -72.28% |
Related companies: CABA · EDIT · KYTX · NAKA · NRC · OMI · SLP
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of DH: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks